FutureMeds @home helps to navigate geographic and short timeframe challenges to maintain retention and protect data integrity.
Vaccine hesitancy continues to pose a challenge not only in low- and middle-income countries but also in many high-income countries such as Germany.
As vaccine take-up can vary significantly within a country, proactive sponsors and CROs are increasingly focused on solutions that can protect the recruitment and retention performance of sites.
Along with other homecare visit providers, FutureMeds @home was engaged in such an effort to aid a nationwide flu vaccination trial across Germany.
Our service, with over 12 years of experience, was contracted to support 12 research sites with flexible and rapid homecare visit delivery.
Challenge
The study presented two critical challenges for sites and their respective home visit teams:
Patients needed to report flu-like symptoms within 24 hours
Home Care Visits had to be completed within 5 calendar days of symptom onset
The geographic spread of patients across Germany, combined with strict timing requirements, created logistical complexity and administrative pressure on the homevisit providers.
FutureMeds @home Solution
From our database with over 13000 registered Healthcare Professionals (nurses & physicians), the FutureMeds @home study team consisting of country coordinators, project managers, visit support and equipment management assembled a team of 18 qualified and vetted professionals.
Our goal during the selection process was to remove geographic constraints and enable our team to reach patients within a short timeframe, regardless of their location.
“Thanks to our incredibly dedicated country coordinators and nurses, we managed to organize all requested visits within the allowed time window - whether it was for the next day or on a remote island in Germany, we just made it happen,” commented Aleksandra Magowska, Project Manager, FutureMeds @home
“It is truly a pleasure to work with such a committed team, providing excellent service to the sites that trust us and, most importantly - to the patients who play a crucial role in this important clinical study. Their contribution is what drives progress in medicine, and I am more than grateful to be part of it!”
Key FutureMeds @home results
As of February 26, 2025, our team delivered 40 visits
100% completion rate for scheduled home visits – no cancellations
Successfully conducted extreme-case scenarios, including:
A 700+ km journey to reach a patient on a Baltic Sea island
Completed a visit on December 31, 2024, within 24 hours of the request, despite the holiday period
"As one team, the FutureMeds @home team has shown that no distance is too great, no challenge too daunting. Together, we've achieved a 100% completion rate, delivering crucial care under extreme conditions, proving that with collaboration, dedication, and a shared commitment, we can overcome any obstacle and deliver results that truly matter."
— Nicole Bohrmann, Director of Decentralized Operations
Follow us on LinkedIn
Follow FutureMeds on LinkedIn and join a growing group of engaged, passionate healthcare and pharmaceutical professionals who are on a mission to accelerate the drug development process and achieve regulatory approval faster so patients can safely access the very latest treatments as soon as possible.
Comentários